Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for diabetes mellitus: Difference between revisions
Esther Lee (talk | contribs) No edit summary |
Esther Lee (talk | contribs) No edit summary |
||
Line 8: | Line 8: | ||
|- | |- | ||
| colspan="1" style="text-align:center; background:LightGreen"| | | colspan="1" style="text-align:center; background:LightGreen"| | ||
[[ACC/AHA guidelines classification scheme#Classification of Recommendations| | [[ACC/AHA guidelines classification scheme#Classification of Recommendations|Class I]] | ||
|- | |- | ||
| bgcolor="LightGreen"| | | bgcolor="LightGreen"| | ||
Line 17: | Line 17: | ||
|- | |- | ||
| colspan="1" style="text-align:center; background:LemonChiffon"| | | colspan="1" style="text-align:center; background:LemonChiffon"| | ||
[[ACC/AHA guidelines classification scheme#Classification of Recommendations| | [[ACC/AHA guidelines classification scheme#Classification of Recommendations|Class IIa]] | ||
|- | |- | ||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.''' For patients with [[UA/NSTEMI]] and multivessel disease, [[CABG]] with use of the internal mammary arteries can be beneficial over [[PCI]] in patients being treated for [[diabetes mellitus]].148 ([[ACC/AHA guidelines classification scheme#Level of Evidence|Level B]])<nowiki>"</nowiki> | |bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.''' For patients with [[UA/NSTEMI]] and multivessel disease, [[CABG]] with use of the internal mammary arteries can be beneficial over [[PCI]] in patients being treated for [[diabetes mellitus]].148 ([[ACC/AHA guidelines classification scheme#Level of Evidence|Level B]])<nowiki>"</nowiki> |
Revision as of 15:27, 9 October 2012
Unstable angina / NSTEMI Microchapters |
Differentiating Unstable Angina/Non-ST Elevation Myocardial Infarction from other Disorders |
Special Groups |
Diagnosis |
Laboratory Findings |
Treatment |
Antitplatelet Therapy |
Additional Management Considerations for Antiplatelet and Anticoagulant Therapy |
Risk Stratification Before Discharge for Patients With an Ischemia-Guided Strategy of NSTE-ACS |
Mechanical Reperfusion |
Discharge Care |
Case Studies |
Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for diabetes mellitus On the Web |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-in-Chief: Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.
ACC / AHA Guidelines for Diabetes Mellitus[1]
"1. Medical treatment in the acute phase of UA/NSTEMI and decisions on whether to perform stress testing, angiography, and revascularization should be similar in patients with and without diabetes mellitus.55,72,81,147 (Level A)" |
"1. For patients with UA/NSTEMI and multivessel disease, CABG with use of the internal mammary arteries can be beneficial over PCI in patients being treated for diabetes mellitus.148 (Level B)" |
"2. PCI is reasonable for UA/NSTEMI patients with diabetes mellitus with single-vessel disease and inducible ischemia.55 (Level B)" |
"3. It is reasonable to use an insulin-based regimen to achieve and maintain glucose levels less than 180 mg/dL while avoiding hypoglycemia* for hospitalized patients with UA/NSTEMI with either a complicated or uncomplicated course.149–152 (Level B)" |
See Also
References
- ↑ 2012 Writing Committee Members. Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR; et al. (2012). "2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". Circulation. 126 (7): 875–910. doi:10.1161/CIR.0b013e318256f1e0. PMID 22800849.